Return To Sender stamp on an envelope
Biotech

Takeda tears up Denali partnership, returning dementia asset

With DNL593 back in Denali's control, the biotech has no further collaborations ongoing with the Japanese pharma.
Darren Incorvaia Apr 6, 2026 1:50pm
Debut

Stipple Bio debuts with $100M to advance oncology asset

Apr 6, 2026 7:00am
A graphic symbolizing one group acquiring another

Anthropic acquires stealth startup Coefficient Bio: reports

Apr 6, 2026 11:07am
Image of brain with hindbrain highlighted

Zeto’s EEG device gets FDA 510(k) clearance for outpatient use

Apr 6, 2026 10:44am
Union Flag Union Jack UK London

US, UK regulators bolster medical device collaboration

Apr 6, 2026 10:20am
handshake deal shake hand arrows ok yes
Favicon Fierce Pharma

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Apr 6, 2026 8:37am
More News
Fierce Pharma

March M&A surge triggers high expectations for 2026

Apr 6, 2026 5:00am
Fierce Healthcare

White House floats 12.5% budget cut for HHS in FY2027

Apr 3, 2026 2:00pm

Syneron closes $150M round to support peptide platform

Apr 3, 2026 9:31am

ADCs, TCEs among ‘exciting things’ on Boehringer's shopping list

Apr 3, 2026 8:40am